Home The Lancet Publishes Landmark Head-to-Head Study Confirming MK6240/XTR006 Superiority in Alzheimer’s Disease Tau Pathology Detection

The Lancet Publishes Landmark Head-to-Head Study Confirming MK6240/XTR006 Superiority in Alzheimer’s Disease Tau Pathology Detection

Jun 08, 2026 10:00 CST Updated Jun 09, 01:43
Sinotau

Radiopharmaceutical R&D and Manufacturing Company

Lantheus

Developer of radiopharmaceuticals, diagnostic imaging agents, and precision medical technology